A team from Australia’s University of New South Wales (UNSW) Sydney has developed an AI-powered breath test for the diagnosis of silicosis.

This rapid and non-invasive method utilises mass spectrometry and AI to detect the lung disease from breath samples, providing results within minutes.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

According to the university, silicosis occurs due to the inhalation of small crystalline particles of silicon dioxide and is a significant occupational health issue in the country.

This research gained backing from the iCare Dust Diseases Board via a Discovery and Innovation grant. The study involved analysing breath samples from 31 subjects with silicosis and 60 healthy controls.

The new technology claims to “differentiate” between affected and unaffected subjects. Those who were to undergo the test were required to breathe into a bag, and the sample was then analysed by a mass spectrometer, to where the breathed content was “pushed”, to identify the molecules that were present.

UNSW noted that the complete process, from breath sampling to analysis, takes under five minutes, making it a practical option for routine worker screening.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Although the test shows significant potential, further validation with larger groups is necessary before it becomes a standard screening tool.

The compact size of the instrument makes it suitable for clinical settings, and future developments may allow for on-site testing.

The researchers aim to refine the technique and incorporate it into screening programmes, as well as to distinguish silicosis from other lung conditions.

Silica exposure can also lead to other diseases, including lung fibrosis and lung cancer.

UNSW’s School of Chemistry professor William Alexander Donald said: “In human breath, there are thousands of organic molecules that you breathe out.

“Our instrument can make a profile of someone’s breath, and then we feed that into an artificial intelligence algorithm that’s really good at finding patterns. In this case, it’s looking for patterns in the organic compounds that are present in the breath of people in the early stages of silicosis. And we’re getting very high accuracies, like over 90% accuracy, for just such a simple, non-invasive breath test.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact